GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis

Marco Castellana; Angelo Cignarelli; Francesco Brescia; Luigi Laviola; Francesco Giorgino

doi:10.1002/dmrr.3082

GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.3082 ◽

2018 ◽

Vol 35 (1) ◽

pp. e3082 ◽

Cited By ~ 21

Author(s):

Marco Castellana ◽

Angelo Cignarelli ◽

Francesco Brescia ◽

Luigi Laviola ◽

Francesco Giorgino

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Therapy ◽

Receptor Agonist ◽

Meta Analysis ◽

Bolus Insulin ◽

Basal Bolus

Download Full-text

Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Endocrine ◽

10.1007/s12020-015-0718-3 ◽

2015 ◽

Vol 51 (3) ◽

pp. 417-428 ◽

Cited By ~ 51

Author(s):

Dario Giugliano ◽

Paolo Chiodini ◽

Maria Ida Maiorino ◽

Giuseppe Bellastella ◽

Katherine Esposito

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Therapy ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Premixed Insulin ◽

Randomized Controlled ◽

Basal Bolus

Download Full-text

Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: A systematic review and meta-analysis

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.2885 ◽

2017 ◽

Vol 33 (5) ◽

pp. e2885 ◽

Cited By ~ 14

Author(s):

Merete B. Christensen ◽

Anders Gotfredsen ◽

Kirsten Nørgaard

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Critically Ill ◽

Critically Ill Patients ◽

Meta Analysis ◽

Inpatient Management ◽

Bolus Insulin ◽

Basal Bolus

Download Full-text

Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Diabetic Medicine ◽

10.1111/dme.12694 ◽

2015 ◽

Vol 32 (5) ◽

pp. 585-594 ◽

Cited By ~ 26

Author(s):

C. Wang ◽

J. Mamza ◽

I. Idris

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Insulin Regimen ◽

Randomized Controlled ◽

Bolus Insulin ◽

Basal Bolus

Download Full-text

Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)

Case Medical Research ◽

10.31525/ct1-nct04196231 ◽

2019 ◽

Author(s):

Keyword(s):

Type 2 Diabetes ◽

Receptor Agonist ◽

Insulin Regimen ◽

Bolus Insulin ◽

Basal Bolus

Download Full-text

Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(13)70006-8 ◽

2013 ◽

Vol 1 (1) ◽

pp. 28-34 ◽

Cited By ~ 102

Author(s):

Caroline Kaercher Kramer ◽

Bernard Zinman ◽

Ravi Retnakaran

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Therapy ◽

Intensive Insulin Therapy ◽

Meta Analysis ◽

Short Term

Download Full-text

Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial)

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)79131-5 ◽

2008 ◽

Vol 2008 ◽

pp. 14-15

Author(s):

L. Kennedy

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Randomized Study ◽

Inpatient Management ◽

Bolus Insulin ◽

Basal Bolus

Download Full-text

Basal-bolus insulin therapy during switching over from continuous intra venous regular insulin to sub cutaneous insulin therapy as compared to conventional regimens in type-2 diabetes patients admitted in intensive care unit

International Journal of Research in Medical Sciences ◽

10.18203/2320-6012.ijrms20162926 ◽

2016 ◽

pp. 4014-4021

Author(s):

Subrata Halder ◽

Priyankar Biswas ◽

Debasis Sarkar ◽

Bikram Saha

Keyword(s):

Type 2 Diabetes ◽

Intensive Care Unit ◽

Intensive Care ◽

Insulin Therapy ◽

Regular Insulin ◽

Bolus Insulin ◽

Basal Bolus ◽

Diabetes Patients

Download Full-text

Switching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimens

Endocrinología y Nutrición (English Edition) ◽

10.1016/j.endoen.2012.11.007 ◽

2013 ◽

Vol 60 (5) ◽

pp. 249-253

Author(s):

Irene Vinagre ◽

Juan Sánchez-Hernández ◽

José Luis Sánchez-Quesada ◽

Miguel Ángel María ◽

Alberto de Leiva ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Bolus Insulin ◽

Basal Bolus ◽

Term Type ◽

Diabetes Patients

Download Full-text

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.06.009 ◽

2019 ◽

Vol 154 ◽

pp. 101-115 ◽

Cited By ~ 5

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Lorenzo Scappaticcio ◽

Miriam Longo ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Efficacy and safety of the addition of a dipeptidyl peptidase-4 inhibitor to insulin therapy in patients with type 2 diabetes: A systematic review and meta-analysis

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2016.03.011 ◽

2016 ◽

Vol 116 ◽

pp. 86-95 ◽

Cited By ~ 16

Author(s):

Yeong Gi Kim ◽

Se Hee Min ◽

Seokyung Hahn ◽

Tae Jung Oh ◽

Kyong Soo Park ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Therapy ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Efficacy And Safety ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text